EUVIMED · CrossrefZeitschrift
Current Opinion in Infectious Diseases
ISSN 0951-7375 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Combination therapy for fungal diseases: the role of immunotherapy in the present and the future
Novel antifungal agents for treating endemic mycoses: hope on the horizon?
Rates of azole resistance in aspergillosis: a worldwide overview
Using bacteriophage cocktails in MDR Gram-negative infections: a practical manual
Managing KPC infections in daily practice: when BLBLIs are interchangeable – and when they are not
Antiviral targets in the prevention and treatment of measles
Machine learning to differentiate colonization from infection in multidrug-resistant Gram-negative bacteria: implications for further research
Fungal diseases in burn and blast-injured patients: tensions are rising, and awareness must keep pace
Reducing antibiotic burden in gram-negative bacteraemia: duration optimization and early oral transition
Optimizing cefiderocol use in clinical practice
Endemic Mycoses in 2026: can we keep the pace of redrawing maps?
Adenovirus infection after cellular therapy: diagnostic and therapeutic challenges
Respiratory syncytial virus respiratory infection morbidity and mortality in adult populations
Fungal threats in motion: resistance rising, maps shifting, therapies evolving
Screening for multidrug-resistant organism: clinical benefit or unquestioned routine
Severe strongyloidiasis and Gram-negative bacterial superinfections: epidemiology, clinical implications, and therapeutic strategies
Editorial introductions
Aspergillus–Mucorales co-infections: implications for first-line antifungal treatment?
HIV: tackling inequalities and sustaining access to care in an era of global health regression
Islatravir: a first-in-class nucleoside reverse transcriptase translocation inhibitor for HIV treatment
Unresolved questions in pediatric dengue: from disease mechanisms to prevention
Antiviral prophylaxis against herpesviruses (herpes simplex virus, varicella-zoster virus and cytomegalovirus) among patients with cancer
Epidemiology, treatment and outcomes of antimicrobial-resistant infections in hematopoietic stem cell transplant recipients
Managing skin infections in burn patients: principles and pitfalls
Perioperative surgical prophylaxis in the era of multidrug-resistant gram-negatives
Vitamin D for tuberculosis or acute respiratory infections: lost in translation?
From clinical trials to daily practice: how to adequately administer sulbactam-durlobactam? alone or combined with imipenem?
How I manage patients with New Delhi metallo-beta-lactamase and OXA-48-producing Enterobacterales infections: a practical approach
Is it possible to identify genotypes underlying resistant phenotypes in Gram-negative pathogens?
Combatting antimicrobial-resistant Neisseria gonorrhoeae: new antibiotics and the pipeline of antigonococcal therapeutics
Jahrgänge
2026 · 682025 · 852024 · 812023 · 892022 · 862021 · 972020 · 772019 · 982018 · 872017 · 832016 · 952015 · 892014 · 872013 · 832012 · 1012011 · 1062010 · 972009 · 932008 · 992007 · 862006 · 842005 · 812004 · 822003 · 812002 · 792001 · 932000 · 801999 · 761998 · 1081997 · 1151996 · 1091995 · 1201994 · 1171993 · 961992 · 1231991 · 1371990 · 1471989 · 1321988 · 84
EUVIMED